Stephanie Jones
Physical Medicine & Rehabilitation · Reno, NVNPI 1841685005
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,250 of the $1,671 with a category attached, or 74.8%. Medical Device Business Services, Inc. accounts for 74.8% of it on its own, with 4 other manufacturers making up the rest. 2023 is the largest year on record at $1,491, more than ten times the $119 reported in 2021.
Across 11 payments — averaging $151.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1K
- Coloplast$177
- Medtronic$119
- Merz Pharmaceuticals, LLC$110
- AbbVie$15
What the payments were for
- Travel & lodging$1,25075%
- Food & beverage$33620%
- Education$855%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 1 | $1,250 |
| Coloplast | 6 | $177 |
| Medtronic | 1 | $119 |
| Merz Pharmaceuticals, LLC | 2 | $110 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$119
How this compares
$1,671 in reported general payments places this provider in the 80th percentile of 98 physical medicine & rehabilitation providers in Nevada.
See all physical medicine & rehabilitation providers in Nevada →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 44 | $24,758 |
| FarxigaDapagliflozin Propanediol | 11 | $6,225 |
| Gabapentin | 75 | $855 |
| Midodrine Hcl | 16 | $716 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 14 | $521 |
| Atorvastatin Calcium | 65 | $474 |
| Tamsulosin Hcl | 45 | $452 |
| Amiodarone Hcl | 22 | $440 |
| Baclofen | 12 | $435 |
| Metoprolol Succinate | 39 | $427 |
| Losartan Potassium | 50 | $404 |
| Rosuvastatin Calcium | 30 | $381 |
| Digoxin | 12 | $369 |
| Omeprazole | 50 | $330 |
| Oxycodone Hcl | 84 | $314 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Reno
- Sharlene SuReno$15K
- Casey KeatingReno$13K
- Andrew HsuReno$7K
- Jesson BaumgartnerReno$3K
- Martin ArraizReno$3K
- Benjamin PenceReno$2K
- Bruce WitmerReno$2K
- John ReyherReno$1K
- Elie ElovicReno$689
- Emma RicklesReno$685
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.